Benign causes of 18-FDG uptake on whole body imaging

Seminars in Nuclear Medicine

Volumn 28, Issue 4, 1998, Pages 352-358

  Bakheet, S M ^a   Powe, J ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTIFACT; HUMAN; IMAGE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE DISTRIBUTION; REVIEW; TISSUE DISTRIBUTION; WHOLE BODY SCINTISCANNING;

EID: 0031784418     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(98)80038-X     Document Type: Article

References (67)

1. Valk P Pounds T Tesar RD Cost effectiveness of PET imaging in clinical oncology Nucl Med Biol 23 1996 737 743
2. 18F-FDG in oncology: A clinical update Nucl Med Biol 23 1996 717 735
3. Wahl R Clinical oncology update: The emerging role of positron emission tomography: Part 2 Devita VT Hellman S Rosenberg S Cancer principles & practice in oncology 5th Ed. 1997 Lippincott-Raven Press NJ 1 24
4. Cook G JR Fogelman I Maisey MN Normal physiological and benign pathological variants of 18-Fluoro-2-Deoxyglucose positron emission tomography scanning: Potential for error in interpretation Sem Nucl Med XXVI 1996 308 314
5. Bairamian D DiChiro G Blume H Pituitary adenoma with seizures: PET demonstration of reduced glucose utilization in the medial temporal lobe J Comput Assisst Tomogr 10 1986 529 532
6. De Souza B Brunetti A Fulham MJ Pituitary microadenoma: A PET study Radiology 177 1990 39 44
7. Yasuda S Shohtsu A Ide M Diffuse F-18 FDG uptake in chronic thyroiditis Clin Nucl Med 22 1997 341
8. Yasuda S Ide S Takagi T Setogawa T Cancer screening using whole-body FDG PET Proc 8th annual meeting Institute Clinical PET 1996 Institute for Clinical PET Fairfax, Virginia
9. Keyes JW Jr Harkness BA Greven KM Salivary gland tumors: Pretherapy evaluation with PET Radiology 192 1994 99 102
10. McGuirt WF Keyes JW Jr Greven KM Preoperative identification of benign versus malignant parotid masses: A comparative study including positron emission tomography Laryngoscope 105 1995 579 584
11. Meyer MA Hubner KF Raja S Sequential positron emission tomographic evaluations of brain metabolism in acute herpes encephalitis J Neuroimag 4 1994 104 105
12. Meyer MA Frey KA Schwaiger M Discordance between F-18 fluorodeoxyglucose uptake and contrast enhancement in a brain abscess Clin Nucl Med 18 1993 682 684
13. Sasaki M Ichiya Y Kuwabara Y Ringlike uptake of 18-FDG in brain abscess: A PET study J Comput Assist Tomogr 14 1990 486 487
14. Hanson MW Glantz MJ Hoffman JM FDG-PET in the selection of brain lesions for biopsy J Comput Assist Tomogr 15 1991 796 801
15. Strauss LG Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnosis of oncological patients Eur J Nucl Med 23 1996 1409 1415
16. Kado H Ogawa T Hatazawa J Radiation induced meningioma evaluated with positron emission tomography with 18-F fluorodeoxyglucose A J Neurorad 17 1996 937 938
17. Borbely K Fulham MJ Broks RA Di Chiro G PET-Fluorodeoxyglucose of cranial and spinal neuromas J Nucl Med 33 1992 1931 1934
18. Bohlega S Al Watban J Tulbah A Cerebral manifestations of Erdheim-Chester disease: clinical and radiological findings Neurology 49 1997 1702 1705
19. Joensuu H Ahonen A Klemi PJ 18-F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy Eur J Nucl Med 13 1988 502 506
20. Neuman DR Esselstyn CB MacIntyre WJ Parathyroid adenoma localization by PET FDG J Comp Assist Tomogr 17 1993 976 977
21. Neumann DR Esselstyn CB MacIntyre WJ Primary hyperparathyroid: Preoperative parathyroid imaging with regional body FDG PET scan Radiology 192 1994 509 512
22. 18F]Fluoro-2-Deoxy-D-Glucose J Comput Assist Tomogr 17 1993 582 589
23. Avril N Dose J Janicke F Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose J Clin Oncol 14 1996 1848 1857
24. Knopp MV Bischoff HG Evaluation of pulmonary lesions with positron emission tomography Radiologe 34 1994 588 591
25. Knight SB Delbeke D Stewart JR Sandler MP Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy Chest 109 1996 982 988
26. Patz EF Lowe VJ Hoffman JM Focal pulmonary abnormalities: Evaluation with F-18-Fluorodeoxyglucose PET scanning Radiology 188 1993 487 490
27. 18F fluorodeoxyglucose positron emission tomography (FDG PET) J Thorac Cardiovasc Surg 110 1995 130 140
28. Sazon DAD Santiago SM Soo Hoo GW Fluorodeoxyglucose-Positron Emission Tomography in the detection and staging of lung cancer Am J Respir Crit Care Med 153 1996 417 421
29. Scott WJ Schawabe JL Gupta NC Positron emission tomography in lung tumors and mediastinal lymph nodes using 18-F fluorodeoxyglucose. The members of the PET-Lung Tumor Study Group Ann Thorac Surg 58 1994 569 703
30. Kubota K Matsuzawa T Fujiwara T Differential diagnosis of lung tumor with positron emission tomography J Nucl Med 31 1990 1927 1933
31. Paulus P Hustinx R Bury T Radermercker M Rigo P FDG-PET and lung cancer: Evaluation of solitary pulmonary nodule and mediastinal staging Proceedings of the 8th annual meeting of the Institute for Clinical PET 1996 Institute for Clinical PET Fairfax, Virginia
32. Hubner KF Buonocor E Singh SK Characterization of chest masses by FDG positron emission tomography Clin Nucl Med 20 1995 283 298
33. Valind SO Rhodes CG Paltin C Measurements of pulmonary glucose in patients with cryptogenic fibrosing alveolitis and pulmonary sarcoidosis Am Rev Respir Dis 129 1984 A53
34. Inoue T Kim E Komaki R Detecting recurrent or residual lung cancer with FDG-PET J Nucl Med 36 1995 788 793
35. Nieweg OE Kim EE Wong WH Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer Cancer 71 1993 3920 3925
36. Knapp WH Highlights of the annual meeting of the European Association of Nuclear Medicine, Dusseldorf 1994 Eur J Nucl Med 22 1995 69 80
37. 193P Hanson PS Ponto LLB Kirchner PT Diagnostic accuracy of F-18 FDG whole body PET imaging in oncologic patients J Nucl Med 36 1995
38. Bakheet SM Powe J 18-FDG uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer J Nucl Med 39 1998 234 235
39. Frank A Lefkowitz D Jaeger S Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomographic findings Int J Radiat Oncol Biol Phys 32 1995 1495 1512
40. Pantin CF Valind SO Sweatman M Measures of the pulmonary response in cryptogenic fibrosing alveolitis Am Rev Respir Dis 138 1988 1234 1241
41. Slosman DO Spiliopoulos A Keller A Quantitative metabolic PET imaging of a plasma cell granuloma J Thor Imag 9 1994 116 119
42. 18F-fluorodeoxyglucose and positron emission tomography Lancet 347 1996 937 940
43. Goldberg MA Lee MJ Fischman AJ Fluorodeoxyglucose PET of abdominal and pelvic neoplasm: A potential role in oncologic imaging Radiographics 13 1993 1047 1062
44. Patel PM Alibazoglu H Ali A Normal thymic uptake of FDG on PET imaging Clin Nucl Med 21 1996 772 775
45. Meyer MA Diffusely increased colonic F-18 FDG uptake in acute enterocolitis Clin Nucl Med 20 1995 434 435
46. Engenhart R Kimmig BN Strauss LG Therapy monitoring of presacral recurrence after high-dose irradiation. Value of PET scan, CT, CEA, and pain score Strahlenter Onkol 168 1992 203 212
47. Haberkorn U Stauss LG Dimitrakopoulou A PET studies of fuorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy J Nucl Med 32 1991 1485 1490
48. Bares R Klever P Hauptmann S F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer Radiology 192 1994 79 86
49. Stollfuss JC Glatting G Friess H 2-(Flourine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation Radiology 195 1995 339 344
50. Inokuma T Tamaki N Torizuka T Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: Comparison with CT and US Radiology 195 1995 345 352
51. Okazumi S Enomoto K Fukunaga T Evaluation of the cases of benign disease with high accumulation on the examination of 18-F fluorodeoxyglucose PET Kabu Igaku 30 1993 1439 1443
52. Tahara T Ichiya Y Kuwabara Y High 18-fluorodeoxyglucose uptake in abdominal abscess: A PET study J Comput Assist Tomogr 13 1989 829 831
53. Shulkin BL Koeppe RA Francis IR Pheochromocytoma that do not accumulate metaiodobenzyl guanidine: Localization with PET and administration of FDG Radiology 186 1993 711 715
54. Kato T Fukatsu H Ito K Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem Eur J Nucl Med 22 1995 32 39
55. Lai DT Fulham M Stephen M The role of whole body positron emission tomography with 18-Fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver Arch Surg 131 1996 703 707
56. Vitola JV Delbeke D Sandler MP Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver Am J Surg 171 1996 21 26
57. Polisson RP Schoenberg OI Fischman A Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis Arthritis & Rheumatism 35 1995 819 825
58. Meyer M Gast T Raja S Hubner K Increased F-18 FDG accumulation in an acute fracture Clin Nucl Med 19 1994 13 14
59. Adler LP Hodder SL FDG PET for imaging patients with infection and fever of undetermined origin (abstr) Radiology 197(P) 1996 183
60. Yao WK Hoh CK Hawkins RA Quantitative PET imaging of bone marrow glucose metabolism response to hematopoietic cytokines J Nucl Med 36 1995 794 799
61. Adler LR Blair HF Makley JT Noninvasive grading of musculoskeletal tumors using PET J Nucl Med 32 1991 1508 1512
62. Luketich JD Urso K Schauer PR The role of PET in staging esophageal cancer Proceedings of the 8th annual meeting of the Institute for Clinical PET 1996 Institute for clinical PET Fairfax, Virginia
63. Cook GJR Maisey MN Fogelman I Pagets disease of bone: Appearances with 18-FDG PET (abstr) J Nucl Med 37 27(P) 1996
64. Griffeth LK Dehdashti F McGuire AH PET evaluation of soft tissue masses with Fluorine-18 Fluoro-2-deoxy-D-glucose Radiology 182 1992 185 194
65. Van Ginkel RJ Hoekstra HJ Pruim J FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft tissue sarcoma J Nucl Med 37 1996 984 990
66. Lewis PJ Salama A Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis J Nucl Med 35 1994 1 3
67. Engel H Steinert H Buck A Whole-Body PET: Physiological and artifactual Fluorodeoxyglucose accumulation J Nucl Med 37 1996 441 446